# A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma

> **NCT06321250** · PHASE1 · RECRUITING · sponsor: **Jemincare** · enrollment: 80 (estimated)

## Conditions studied

- Renal Cell Carcinoma Metastatic

## Interventions

- **DRUG:** JMKX003948

## Key facts

- **NCT ID:** NCT06321250
- **Lead sponsor:** Jemincare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-14
- **Primary completion:** 2026-05-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-07-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06321250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06321250, "A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT06321250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*